Press release content from Business Wire. The AP news staff was not involved in its creation.
MedX Announces Debt Settlement Agreement
December 22, 2020 GMT
MISSISSAUGA, Ontario (BUSINESS WIRE) Dec 22, 2020
MedX Health Corp. (“MedX”) (TSX-V: MDX) announces that the Company has agreed to settle an amount of $65,000 owing to a professional advisor, subject to all relevant consents and approvals, by issuing 500,000 common shares to the vendor, at a price of $0.13 per share. Regulatory and other consents will include acceptance from the TSX Venture Exchange.
About MedX
MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology. SIAscopy is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-h
Press release content from Business Wire. The AP news staff was not involved in its creation.
MedX Health Corp. Announces the Rollout of DermSecure® in the Netherlands
December 14, 2020 GMT
MISSISSAUGA, Ontario (BUSINESS WIRE) Dec 14, 2020
MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX), a global leader in teledermatology, announces that it has begun the rollout of DermSecure ®, MedX’s skin screening telemedicine platform, across the Netherlands in partnership with national telehealth leader
The Netherlands Institute for Prevention and Health (“IVPG”).
“Telehealth allows us to assess patients, relay test results and provide video consultations with IVPG doctors, ultimately offering greater access to medical specialists during the COVID-19 crisis,” commented Paul Vlaanderen, IVPG Founder & CEO. “This improved access to healthcare specialists has directly resulted in higher quality care and the ability for patients to play a greater role in their
MedX Health Corp. Announces the Rollout of DermSecure in the Netherlands
MedX partners with national telehealth leader IVPG in the Netherlands
Two skin screening clinics opened in November 2020, with more than 800 assessments on close to 500 patients completed to date using MedX s DermSecure platform
IVPG plans to expand to 41 skin assessment clinics by 2022
More than half of all cancers reported in the Netherlands are skin cancers
MedX Health Corp. ( MedX or the Company ) (TSX-V: MDX), a global leader in teledermatology, announces that it has begun the rollout of DermSecure
, MedX s skin screening telemedicine platform, across the Netherlands in partnership with national telehealth leader